The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First-in-man combination phase I study of TAS-114 and S-1 in patients (pts) with advanced solid tumors.
 
Toshihiko Doi
Honoraria - Chugai Pharma; Novartis
Consulting or Advisory Role - Amgen; Lilly; Merck Serono; Otsuka
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Janssen (Inst); Lilly (Inst); Merck Serono (Inst); MSD (Inst); NanoCarrier (Inst); Nippon Boehringer Ingelheim (Inst); Novartis (Inst); Pfizer (Inst); Quintiles (Inst); Sanofi (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Zenyaku Kogyo (Inst)
 
Kiyotaka Yoh
Honoraria - AstraZeneca; Boehringer Ingelheim; Chugai Pharma; Lilly; Pfizer; Sanofi; Taiho Pharmaceutical
Research Funding - AstraZeneca; Bayer; Lilly; Novartis; Takeda
 
Kohei Shitara
Honoraria - Chugai Pharma; Takeda
Consulting or Advisory Role - Bayer; Chugai Pharma; Lilly
Research Funding - Bayer; Chugai Pharma; Daiichi Sankyo; Sanofi; Sumitomo Group; Taiho Pharmaceutical; Yakult Pharmaceutical
 
Hideaki Takahashi
Honoraria - Bristol-Myers Squibb; Novartis
 
Makoto Ueno
Honoraria - Abbott Diagnostics; Lilly
Research Funding - AstraZeneca; Daiichi Sankyo; Kowa; Kyowa Hakko Kirin; Lilly; Merck Serono; Taiho Pharmaceutical; Yakult Pharmaceutical; Zeria Pharmaceutical
 
Satoshi Kobayashi
Honoraria - AstraZeneca; Bayer; Pfizer
Travel, Accommodations, Expenses - Novartis
 
Manabu Morimoto
Honoraria - Bayer; Eisai; Nippon Kayaku; Sumitomo Group
Research Funding - Bayer; Kowa; Kyowa Hakko Kirin; Lilly; Shionogi; Yakult Pharmaceutical
 
Shinichi Ohkawa
Honoraria - Daiichi Sankyo; Eisai; Lilly; MSD; Pfizer; Taiho Pharmaceutical; Yakult Pharmaceutical
Consulting or Advisory Role - Boehringer Ingelheim
Research Funding - AstraZeneca; Chugai Pharma; Lilly; OncoTherapy Science; Sumitomo Group; Taiho Pharmaceutical; Yakult Pharmaceutical
 
Takuji Okusaka
Honoraria - Bayer; Chugai Pharma; Eisai; Lilly; Merck Serono; Novartis; Pfizer; Sumitomo Group; Taiho Pharmaceutical
Consulting or Advisory Role - Amgen; Chugai Pharma; Lilly; NanoCarrier; Nippon Boehringer Ingelheim; Nobelpharma; Novartis; OncoTherapy Science; Ono Pharmaceutical; Sumitomo Group; Taiho Pharmaceutical; Yakult Honsha; Zeria Pharmaceutical
Research Funding - AstraZeneca; Bayer; Chugai Pharma; Eisai; Kowa; Kyowa Hakko Kirin; Lilly; Merck Serono; Nippon Boehringer Ingelheim; Novartis; OncoTherapy Science; Ono Pharmaceutical; Otsuka; Pfizer; Sceti Medical Labo; Shizuoka; Sumitomo Group; Taiho Pharmaceutical; Takeda; Yakult Honsha
 
Hideki Ueno
Honoraria - Taiho Pharmaceutical
Research Funding - Lilly; Taiho Pharmaceutical
 
Chigusa Morizane
Honoraria - Lilly; Novartis; Pfizer; Yakult Honsha
Consulting or Advisory Role - AstraZeneca; Novartis; Yakult Honsha
Research Funding - GlaxoSmithKline (Inst); Nobelpharma (Inst); Pfizer (Inst)
 
Satoshi Shiba
No Relationships to Disclose
 
Naohiro Okano
No Relationships to Disclose
 
Daisuke Naruge
Research Funding - Janssen
 
Fumio Nagashima
Consulting or Advisory Role - Janssen
Research Funding - Daiichi Sankyo; Lilly; Sanofi; Sumitomo Group; Taiho Pharmaceutical
 
Junji Furuse
Honoraria - Ajinomoto; Astellas Pharma; Bayer; Bristol-Myers Squibb; Chugai Pharma; Daiichi Sankyo; Eisai; Hisamitsu Pharmaceutical; Kyowa Hakko Kirin; Lilly; Meiji Seika Kaisha; Merck Serono; Mitsubishi Tanabe Pharma; Nippon Kayaku; Ono Pharmaceutical; Sandoz; Sanofi; Shionogi; Sumitomo Group; Taiho Pharmaceutical; Takeda; Yakult Pharmaceutical
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Boehringer Ingelheim; Chugai Pharma; Eisai; Fujifilm; GlaxoSmithKline; J-Pharma; Janssen; Kowa; Kyowa Hakko Kirin; Merck Serono; Otsuka; Taiho Pharmaceutical; Yakult Pharmaceutical; Zeria Pharmaceutical
Research Funding - Bayer; Bristol-Myers Squibb; Chugai Pharma; Daiichi Sankyo; GlaxoSmithKline; Lilly; Merck Serono; Nippon Kayaku; Novartis; Ono Pharmaceutical; Sanofi; Taiho Pharmaceutical; Takeda; Torii Pharmaceutical; Yakult Pharmaceutical
 
Kazuo Koba
Employment - Novartis (I); Taiho Pharmaceutical
Stock and Other Ownership Interests - Otsuka
 
Kazuharu Noguchi
Employment - Taiho Pharmaceutical